Table 2. Proportion of patients with hemoglobin improvement rate over time.
EPO: Erythropoietin. Hb: Hemoglobin. OR: Odds Ratio. N: Effective Size. M: Month
ROXADUSTAT | EPO | Total | OR (IC 95%) | P-value | |
Increase of Hb (g/dl) | n=53 (%) | n=53 (%) | N=106 (%) | ||
≥ 0.75 after M1 | 24 (61.5) | 15 (38.5) | 39 (36.8) | 2.1 (0.93-4.75) | 0.050 |
≥ 0.75 after M2 | 33 (57.9) | 24 (42.1) | 57 (53.8) | 1.99 (0.91-4.36) | 0.060 |
≥ 0.75 after M3 | 39 (63.9) | 22 (36.1) | 61 (57.5) | 3.93 (1.72-9.01) | 0.000 |
≥ 0.75 after M6 | 36 (54.5) | 30 (45.5) | 66 (62.3) | 1.62 (0.73-3.62) | 0.160 |